Abstract Details

Title Field testing the ICHD 3 beta diagnostic criteria of vestibular migraine

Topic Neuro-ophthalmology/Neuro-otology

Presentation(s) P2 - (-)

Poster/Presentation
Number 155

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Mark Obermann, MD, FAAN (Department of Neurology, Klinikum Weser-Egge) PRESENTER	No disclosure on file
	No disclosure on file
	No disclosure on file
Zaza Katsarava, MD	Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Dagny N. Holle, MD	Dr. Holle has nothing to disclose.